Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study

BACKGROUND: In patients with stable coronary artery disease, aspirin, a statin, and an angiotensin-converting enzyme inhibitor are recommended as first-line agents for secondary prevention. Subgroup analyses of the previously published Hungarian Perindopril plus Amlodipine in PAtients with Coronary...

Descripción completa

Detalles Bibliográficos
Autor principal: Dézsi, Csaba András
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991222/
https://www.ncbi.nlm.nih.gov/pubmed/29557300
http://dx.doi.org/10.1177/0300060518760158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991222/
https://www.ncbi.nlm.nih.gov/pubmed/29557300
http://dx.doi.org/10.1177/0300060518760158

Ejemplares similares